M&AHealthcareSIGNED
Biovance Capital, Arcano Partners, and EIC Fund Invest €11 Million in Vaxdyn
Value
€11M
Acquirer
Biovance Capital, Arcano Partners, EIC Fund
Target
Vaxdyn
Biovance Capital, Arcano Partners, and the EIC Fund have jointly invested €11 million in Vaxdyn. The funding is intended to support Vaxdyn's growth and development in the biotechnology sector.
The Meridian Weekly
The week's largest deals and the Iberian ones, every Monday. Free.